Hold the phone on any claim that autologous cells may offer an advantage over off-the-shelf technologies. In fact, it's a highly debated field, the obvious issue being, the person suffers a major disease condition...so their own cells are not that crash hot to begin with!
Much to be said for the off-the-shelf approach and many fold cheaper in the health marketplace too!
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)